newsfilter
← Latest News
GlobeNewswire·

Morphic to Present at the 41st Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ:MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today